The chemical structures, biosynthesis, and biological activities of secondary metabolites from the culinary-medicinal mushrooms of the genus Hericium: a review

Abstract

Fungal phytochemicals derived from higher fungi, particularly those from the culinary-medicinal genus Hericium, have gained significant attention in drug discovery and healthcare. This review aims to provide a comprehensive analysis of the chemical structures, biosynthetic pathways, biological activities, and pharmacological properties of monomeric compounds isolated from Hericium species. Over the past 34 years, 253 metabolites have been identified from various Hericium species, including cyathane diterpenes, alkaloids, benzofurans, chromenes, phenols, pyrones, steroids, and other miscellaneous compounds. Detailed investigations into the biosynthesis of erinacines, a type of cyathane diterpene, have led to the discovery of novel cyathane diterpenes. Extensive research has highlighted the biological activities and pharmacological properties of Hericium-derived compounds, with particular emphasis on their neuroprotective and neurotrophic effects, immunomodulatory capabilities, anti-cancer activity, antioxidant properties, and antimicrobial actions. Erinacine A, in particular, has been extensively studied. Genomic, transcriptomic, and proteomic analyses of Hericium species have facilitated the discovery of new compounds and provided insights into enzymatic reactions through genome mining. The diverse chemical structures and biological activities of Hericium compounds underpin their potential applications in medicine and as dietary supplements. This review not only advances our understanding of Hericium compounds but also encourages further research into Hericium species within the realms of medicine, health, functional foods, and agricultural microbiology. The broad spectrum of compound types and their diverse biological activities present promising opportunities for the development of new pharmaceuticals and edible products.

Keywords

Hericium / Secondary metabolites / Biological activity / Biosynthesis

References

[1] He MQ, Zhao RL, Hyde KD, et al. Notes, outline and divergence times of Basidiomycota[J]. Fungal Divers, 2019, 99(1): 105-367.

[2] Choi JH. Biologically functional molecules from mushroom-forming fungi[J]. Biosci Biotechnol Biochem, 2018, 82(3): 372-382.

[3] Lin HC, Hewage RT, Lu YC, et al. Biosynthesis of bioactive natural products from Basidiomycota[J]. Org Biomol Chem, 2019, 17(5): 1027-1036.

[4] Sandargo B, Chepkirui C, Cheng T, et al. Biological and chemical diversity go hand in hand: Basidiomycota as source of new pharmaceuticals and agrochemicals[J]. Biotechnol Adv, 2019, 37(6): 107344.

[5] Thongbai B, Rapior S, Hyde KD, et al. Hericium erinaceus, an amazing medicinal mushroom[J]. Mycol Prog, 2015, 14(10): 91-114.

[6] Lee KF, Tung SY, Teng CC, et al. Post-treatment with erinacine A, a derived diterpenoid of H. erinaceus, attenuates neurotoxicity in MPTP model of Parkinson’s disease[J]. Antioxidants, 2020, 9(2): 137.

[7] Tsai TT, Chin CC, Li YL, et al. Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer’s disease-related pathologies in APPswe/PS1dE9 transgenic mice[J]. J Biomed Sci, 2016, 23(1): 49.

[8] Federico B, Elisa R, Daniela R, et al. Hericium erinaceus in neurodegenerative diseases: from bench to bedside and beyond, how far from the shoreline[J]. J Fungi, 2023, 9(5): 551.

[9] Kawagishi H, Zhuang C. Compounds for dementia from Hericium erinaceum[J]. Drug Future, 2008, 33: 149.

[10] Rupcic Z, Rascher M, Kanaki S, et al. Two new cyathane diterpenoids from mycelial cultures of the medicinal mushroom Hericium erinaceus and the rare species, Hericium flagellum [J]. Int J Mol Sci, 2018, 19( 3): 740.

[11] Gabrielle B, Florencia ZB, Andreia R, et al. Anticancer diterpenes of African natural products: mechanistic pathways and preclinical developments[J]. Phytomedicine, 2024, 129: 155634.

[12] Hiraki E, Furuta S, Kuwahara R, et al. Anti-obesity activity of Yamabushitake (Hericium erinaceus) powder in ovariectomized mice, and its potentially active compounds[J]. J Nat Med, 2017, 71(3): 482-491.

[13] Wang LY, Huang CS, Chen YH, et al. Anti-inflammatory effect of erinacine C on NO production through down-regulation of NF-κB and activation of Nrf2-mediated HO-1 in BV2 microglial cells treated with LPS[J]. Molecules, 2019, 24(18): 3317.

[14] Tsai YC, Lin YC, Huang CC, et al. Hericium erinaceus mycelium and its isolated compound, erinacine A, ameliorate high-fat high-sucrose diet-induced metabolic dysfunction and spatial learning deficits in aging mice[J]. J Med Food, 2019, 22(5): 469-478.

[15] Mori K, Inatomi S, Ouchi K, et al. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial[J]. Phytother Res, 2009, 23(3): 367-372.

[16] Li IC, Chang HH, Lin CH, et al. Prevention of early Alzheimer’s disease by erinacine A-enriched Hericium erinaceus mycelia pilot double-blind placebo-controlled study[J]. Front Aging Neurosci, 2020, 12: 155.

[17] Saitsu Y, Nishide A, Kikushima K, et al. Improvement of cognitive functions by oral intake of Hericium erinaceus[J]. Biomed Res, 2019, 40(4): 125-131.

[18] Nagano M, Shimizu K, Kondo R, et al. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake[J]. Biomed Res, 2010, 31(4): 231-237.

[19] Ma BJ, Shen JW, Yu HY, et al. Hericenones and erinacines: stimulators of nerve growth factor (NGF) biosynthesis in Hericium erinaceus[J]. Mycology, 2010, 1(2): 92-98.

[20] Friedman M. Chemistry, nutrition, and health-promoting properties of Hericium erinaceus (Lion’s mane) mushroom fruiting bodies and mycelia and their bioactive compounds[J]. J Agric Food Chem, 2015, 63(32): 7108-7123.

[21] Kai W, Bao SC, Li B, et al. A review of research on the active secondary metabolites of Hericium species[J]. Mycosystema, 2015, (04): 553-568.

[22] Tan YF, Mo JS, Wang YK, et al. The ethnopharmacology, phytochemistry and pharmacology of the genus Hericium[J]. J Ethnopharmacol, 2024, 319: 117353.

[23] Kinghorn AD, Falk H, Gibbons S, et al. Progress in the Chemistry of Organic Natural Products [M]. Spring Nature, 2017.

[24] Qi J, Gao YQ, Kang Sj, et al. Secondary metabolites of bird’s nest fungi: chemical structures and biological activities[J]. J Agric Food Chem, 2023, 71(17): 6513-6524.

[25] Bailly C, Gao JM. Erinacine A and related cyathane diterpenoids: molecular diversity and mechanisms underlying their neuroprotection and anticancer activities[J]. Pharmacol Res, 2020, 159: 104953.

[26] Kawagishi H, Shimada A, Shirai R, et al. Erinacines A, B and C, strong stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum[J]. Tetrahedron Lett, 1994, 35(10): 1569-1572.

[27] Kawagishi H, Simada A, Shizuki K, et al. Erinacine D, a stimulator of NGF-synthesis, from the mycelia of Hericium erinaceum[J]. Heterocycl Commun, 1996, 2(1): 51.

[28] Kawagishi H, Shimada A, Hosokawa S, et al. Erinacines E, F, and G, stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum[J]. Tetrahedron Lett, 1996, 37(41): 7399-7402.

[29] Lee EW, Shizuki K, Hosokawa S, et al. Two novel diterpenoids, erinacines H and I from the mycelia of Hericium erinaceum[J]. Biosci Biotechnol Biochem, 2000, 64(11): 2402-2405.

[30] Hirokazu K, Ayano M, Shinji T, et al. Erinacines J and K from the mycelia of Hericium erinaceum[J]. Tetrahedron, 2006, 62(36): 8463-8466.

[31] Atsushi S, Kawgishi H, Furukawa S, et al. Cyathane derivative and inducer for nerve growth factor production containing the same as active ingredient: Japan [P]. 1996.

[32] Kawagishi H, Kojima F, Okamoto K, et al. Cyathane derivative and nerve growth factor production inducer containing the same and antimicrobial agent: Japan [P]. 1995.

[33] Wei J, Li JY, Feng XL, et al. Unprecedented neoverrucosane and cyathane diterpenoids with anti-neuroinflammatory activity from cultures of the culinary-medicinal mushroom Hericium erinaceus[J]. Molecules, 2023, 28(17): 6380.

[34] Kenmoku H, Sassa T, Kato N. Isolation of erinacine P, a new parental metabolite of cyathane-xylosides, from Hericium erinaceum and its biomimetic conversion into erinacines A and B[J]. Tetrahedron Lett, 2000, 41(22): 4389-4393.

[35] Hiromichi K, Takashi S, Tomonobu T, et al. Erinacine Q, a new erinacine from Hericium erinaceum, and its biosynthetic route to erinacine C in the Basidiomycete[J]. Biosci Biotechnol Biochem, 2002, 66(3): 571-575.

[36] Kenmoku H, Tanka K, Okada K, et al. Erinacol (cyatha-3,12-dien-14β-ol) and 11-O-acetylcyathin A3, new cyathane metabolites from an erinacine Q-producing Hericium erinaceum[J]. Biosci Biotechnol Biochem, 2004, 68(8): 1786-1789.

[37] Ayer WA, Lee SP. Metabolites of bird’s nest fungi. Part 11. diterpenoid metabolites of Cyathus earlei Lloyd[J]. Can J Chem, 1979, 57(24): 3332-3337.

[38] Ma BJ, Zhou Y, Li LZ, et al. A new cyathane-xyloside from the mycelia of Hericium erinaceum[J]. Z Naturforsch B, 2008, 63(10): 1241-1242.

[39] Zhang Z, Liu RN, Tang QJ, et al. A new diterpene from the fungal mycelia of Hericium erinaceus[J]. Phytochem Lett, 2015, 11: 151-156.

[40] Chen L, Yao JN, Chen HP, et al. Hericinoids A-C, cyathane diterpenoids from culture of mushroom Hericium erinaceus[J]. Phytochem Lett, 2018, 27: 94-100.

[41] Chen CC, Tzeng TT, Chen CC, et al. Erinacine S, a rare sesterterpene from the mycelia of Hericium erinaceus[J]. J Nat Prod, 2016, 79(2): 438-441.

[42] Kawagishi H, Ando M, Mizuno T. Hericenone A and B as cytotoxic principles from the mushroom Hericium erinaceum[J]. Tetrahedron Lett, 1990, 31(3): 373-376.

[43] Shoji K, Hidetsugu T, Yuichi H, et al. Divergent synthesis of bioactive resorcinols isolated from the fruiting bodies of Hericium erinaceum: total syntheses of hericenones A, B, and I, hericenols B-D, and erinacerins A and B[J]. J Org Chem, 2014, 79(11): 5819-5822.

[44] Yaoita Y, Danbara K, Kikuchi M. Two new aromatic compounds from Hericium erinaceum (Bull. : Fr.) Pers[J]. Chem Pharm Bull, 2005, 53(9): 1202-1203.

[45] Yasuo K, Masahiko N, Hiromitsu N, et al. Hericerin, a new pollen growth inhibitor from the mushroom Hericium erinaceum[J]. Agric Biol Chem, 1991, 55(10): 2673-2674.

[46] Miyazawa M, Takahashi T, Horibe I, et al. Two new aromatic compounds and a new d-arabinitol ester from the mushroom Hericium erinaceum[J]. Tetrahedron, 2012, 68(7): 2007-2010.

[47] Shoji K, Tomoharu I, Ami A, et al. Total synthesis and structural revision of hericerin[J]. J Org Chem, 2012, 77(13): 5819-5822.

[48] Yaoita Y, Yonezawa S, Kikuchi M, et al. A new geranylated aromatic compound from the mushroom Hericium erinaceum[J]. Nat Prod Commun, 2012, 7(4): 527-528.

[49] Kim KH, Noh HJ, Choi SU, et al. Isohericenone, a new cytotoxic isoindolinone alkaloid from Hericium erinaceum[J]. J Antibiot, 2012, 65(11): 575-577.

[50] Wang K, Bao L, Qi Q, et al. Erinacerins C-L, isoindolin-1-ones with α-glucosidase inhibitory activity from cultures of the medicinal mushroom Hericium erinaceus[J]. J Nat Prod, 2015, 78(1): 146-154.

[51] Wittstein K, Rascher M, Rupcic Z, et al. Corallocins A-C, nerve growth and brain-derived neurotrophic factor inducing metabolites from the mushroom Hericium coralloides[J]. J Nat Prod, 2016, 79(9): 2264-2269.

[52] Chen L, Li ZH, Yao JN, et al. Isoindolinone-containing meroterpenoids with α-glucosidase inhibitory activity from mushroom Hericium caput-medusae[J]. Fitoterapia, 2017, 122: 107-114.

[53] Ashour A, Amen Y, Allam AE, et al. New isoindolinones from the fruiting bodies of the fungus Hericium erinaceus[J]. Phytochem Lett, 2019, 32: 10-14.

[54] Wang XL, Xu KP, Long HP, et al. New isoindolinones from the fruiting bodies of Hericium erinaceum[J]. Fitoterapia, 2016, 111: 58-65.

[55] Wang K, Bao L, Ma K, et al. Eight new alkaloids with PTP1B and α-glucosidase inhibitory activities from the medicinal mushroom Hericium erinaceus[J]. Tetrahedron, 2015, 71(51): 9557-9563.

[56] Lin CF, Shiao YJ, Chen CC, et al. A xanthurenate and an isoindolinone from the mycelia of Hericium erinaceum[J]. Phytochem Lett, 2018, 26: 218-221.

[57] Ryu SH, Hong SM, Khan Z, et al. Neurotrophic isoindolinones from the fruiting bodies of Hericium erinaceus[J]. Bioorg Med Chem Lett, 2021, 31: 127714.

[58] Sum WC, Ebada SS, Kirchenwitz M, et al. Hericioic acids A-G and hericiofuranoic acid; neurotrophic agents from cultures of the European mushroom Hericium flagellum[J]. J Agric Food Chem, 2023, 71(29): 11094-11103.

[59] Song X, Gaascht F, Schmidt-Dannert C, et al. Discovery of antifungal and biofilm preventative compounds from mycelial cultures of a unique North American Hericium sp. fungus [J]. Molecules, 2020, 25( 4): 963.

[60] Homma Y, Suzuki T, Ogura M, et al. Prenyloxyquinoline carboxylic-acid derivative: Japan[P]. 2014.

[61] Kim JC, Lee YW, Tamura H, et al. Sambutoxin: a new mycotoxin isolated from Fusarium sambucinum[J]. Tetrahedron Lett, 1995, 36(7): 1047-1050.

[62] Li LN, Wang L, Cheng YN, et al. Discovery and characterization of 4-hydroxy-2-pyridone derivative sambutoxin as a potent and promising anticancer drug candidate: activity and molecular mechanism[J]. Mol Pharm, 2018, 15(11): 4898-4911.

[63] Go EB, Kim LJ, Nelson HM, et al. Biosynthesis of the Fusarium mycotoxin (-)-sambutoxin[J]. Org Lett, 2021, 23(20): 7819-7823.

[64] Breinholt J, Ludvigsen S, Rassing BR, et al. Oxysporidinone: a novel, antifungal N-methyl-4-hydroxy-2-pyridone from Fusarium oxysporum[J]. J Nat Prod, 1997, 60(1): 33-35.

[65] Li LN, Wang L, Guo XL. Chemical constituents from the culture of the fungus Hericium alpestre[J]. J Asian Nat Prod Res, 2019, 21(8): 735-741.

[66] Zhang CC, Cao CY, Kubo M, et al. Chemical constituents from Hericium erinaceus promote neuronal survival and potentiate neurite outgrowth via the TrkA/Erk1/2 Pathway[J]. Int J Mol Sci, 2017, 18(8): 1659.

[67] Yamashita N, Sakata K, Ina H, et al. Isolation of nicotinamide from Mallotus leaves as an attaching repellent against the blue mussel, Mytilus edulis [J]. Agric Biol Chem, 1989, 53( 12): 3351-3352.

[68] Li W, Zhou W, Lee DS, et al. Hericirine, a novel anti-inflammatory alkaloid from Hericium erinaceum[J]. Tetrahedron Lett, 2014, 55(30): 4086-4090.

[69] Lu QQ, Tian JM, Wei J, et al. Bioactive metabolites from the mycelia of the basidiomycete Hericium erinaceum[J]. Nat Prod Res, 2014, 28(16): 1288-1292.

[70] Nachshol C, Jacob C, Mikheil DA, et al. Chemical composition and nutritional and medicinal value of fruit bodies and submerged cultured mycelia of culinary-medicinal higher Basidiomycetes mushrooms[J]. Int J Med Mushrooms, 2014, 16(3): 273-291.

[71] Rama RAV, Reddy RG. First unambiguous total synthesis of hericenone A: proposed structure revised[J]. Tetrahedron Lett, 1992, 33(28): 4061-4064.

[72] Yaoita Y, Kikuchi M. Constituents of mushrooms. XXV. Structures of new aromatic compounds from the fruiting bodies of Hericium erinaceum (Bull. : Fr.) Pers.[J]. J Tohoku Pharm Univer, 2005, 52: 39-42.

[73] Zhang CC, Yin X, Cao CY, et al. Chemical constituents from Hericium erinaceus and their ability to stimulate NGF-mediated neurite outgrowth on PC12 cells[J]. Bioorg Med Chem Lett, 2015, 25(22): 5078-5082.

[74] Ueda K, Tsujimori M, Kodani S, et al. An endoplasmic reticulum (ER) stress-suppressive compound and its analogues from the mushroom Hericium erinaceum[J]. Bioorg Med Chem, 2008, 16: 9467-9470.

[75] Wu J, Tokunaga T, Kondo M, et al. Erinaceolactones A to C, from the culture broth of Hericium erinaceus[J]. J Nat Prod, 2015, 78(1): 155-158.

[76] Wang XL, Gao J, Li J, et al. Three new isobenzofuranone derivatives from the fruiting bodies of Hericium erinaceus[J]. J Asian Nat Prod Res, 2017, 19(2): 134-139.

[77] Li J, Wang XL, Li G, et al. Two new isobenzofuranone derivatives from the fruiting bodies of Hericium erinaceus[J]. J Asian Nat Prod Res, 2017, 19(11): 1108-1113.

[78] Kobayashi S, Tamura T, Koshishiba M, et al. Total synthesis, structure revision, and neuroprotective effect of hericenones C-H and their derivatives[J]. J Org Chem, 2021, 86(3): 2602-2620.

[79] Kim JY, Woo EE, Lee IK, et al. New antioxidants from the culture broth of Hericium coralloides[J]. J Antibiot, 2018, 71(9): 822-825.

[80] Kleinwächter P, Schlegel B, Dörfelt H, et al. Spirobenzofuran, a new bioactive metabolite from Acremonium sp. HKI 0230[J]. J Antibiot, 2001, 54(6): 526-527.

[81] Hirokazu K, Motoharu A, Kayoko S, et al. Chromans, hericenones F, G and H from the mushroom Hericium erinaceum[J]. Phytochemistry, 1993, 32(1): 175-178.

[82] Wu J, Uchida K, Ridwan AY, et al. Erinachromanes A and B and erinaphenol A from the culture broth of Hericium erinaceus[J]. J Agric Food Chem, 2019, 67(11): 3134-3139.

[83] Nielsen KF, Smedsgaard J. Fungal metabolite screening: database of 474 mycotoxins and fungal metabolites for dereplication by standardised liquid chromatography-UV-mass spectrometry methodology[J]. J Chromatogr A, 2003, 1002(1-2): 111-136.

[84] Gao L, Xu X, Yang J. Chemical constituents of the roots of Rheum officinale[J]. Chem Nat Compd, 2013, 49(4): 603-605.

[85] Qian F, Xu G, Du S, et al. Isolation and identification of two new pyrone compounds from the culture of Hericium erinaceus[J]. Acta Pharm Sin B, 1990, 25(07): 522-525.

[86] Ueda K, Kodani S, Kubo M, et al. Endoplasmic reticulum (ER) stress-suppressive compounds from scrap cultivation beds of the mushroom Hericium erinaceum[J]. Biosci Biotechnol Biochem, 2009, 73(8): 1908-1910.

[87] Okamoto K, Sakai T, Shimada A, et al. Antimicrobial chlorinated orcinol derivatives from mycelia of Hericium erinaceum[J]. Phytochemistry, 1993, 34(5): 1445-1446.

[88] Liu JH, Li L, Shang XD, et al. Anti-helicobacter pylori activity of bioactive components isolated from Hericium erinaceus[J]. J Ethnopharmacol, 2016, 183: 54-58.

[89] Aurelio DVFR.New serine derivatives, process for their preparation and their use in human therapy [P]. 1990.

[90] Arnone A, Cardillo R, Nasini G, et al. Secondary mold metabolites: part 46. Hericenes A-C and erinapyrone C, new metabolites produced by the fungus Hericium erinaceus[J]. J Nat Prod, 1994, 57(5): 602-606.

[91] Chen Z, Yuan X, Buchanan P, et al. Isolation and determination of lipophilic mycochemicals from a New Zealand edible native mushroom Hericium novae-zealandiae[J]. J Food Compos Anal, 2020, 88: 103456.

[92] Ma BJ, Yu HY, Shen JW, et al. Cytotoxic aromatic compounds from Hericium erinaceum[J]. J Antibiot, 2010, 63(12): 713-715.

[93] Li W, Sun YN, Zhou W, et al. Erinacene D, a new aromatic compound from Hericium erinaceum[J]. J Antibiot, 2014, 67(10): 727-729.

[94] Ma BJ, Ma JC, Ruan Y. Hericenone L, a new aromatic compound from the fruiting bodies of Hericium erinaceums[J]. Chin J Nat Med, 2012, 10(5): 363-365.

[95] Chen B, Han J, Bao L, et al. Identification and α-glucosidase inhibitory activity of meroterpenoids from Hericium erinaceus[J]. Planta Med, 2020, 86(8): 571-578.

[96] Hirokazu K, Ryoko S, Hideki S, et al. Erinapyrones A and B from the cultured mycelia of Hericium erinaceum[J]. Chem Lett, 1992, 21(12): 2475-2476.

[97] Yaoita Y, Kikuchi M, Machida K. Chapter 1: Terpenoids and Sterols from Mushrooms. Stud Nat Prod Chem[M]. Elsevier, 2015: 1-32.

[98] Kawagishi H. Chemical studies on bioactive compounds related to higher fungi[J]. Biosci Biotechnol Biochem, 2021, 85(1): 1-7.

[99] Takaishi Y, Uda M, Ohashi T, et al. Glycosides of ergosterol derivatives from Hericium erinacens[J]. Phytochemistry, 1991, 30(12): 4117-4120.

[100] Wei L, Wei Z, Bean SS, et al. Sterol fatty acid esters from the mushroom Hericium erinaceum and their PPAR transactivational effects[J]. J Nat Prod, 2014, 77(12): 2611-2618.

[101] Li W, Zhou W, Cha JY, et al. Sterols from Hericium erinaceum and their inhibition of TNF-α and NO production in lipopolysaccharide-induced RAW 264.7 cells[J]. Phytochemistry, 2015, 115: 231-238.

[102] Li W, Lee SH, Jang HD, et al. Antioxidant and anti-osteoporotic activities of aromatic compounds and sterols from Hericium erinaceum[J]. Molecules, 2017, 22(1): 108.

[103] Li W, Bang SH, Lee C, et al. Sterols, aromatic compounds, and cerebrosides from the Hericium erinaceus fruiting body[J]. Biochem Syst Ecol, 2017, 70: 254-259.

[104] Xie G, Tang L, Xie Y, et al. Secondary metabolites from Hericium erinaceus and their anti-inflammatory activities[J]. Molecules, 2022, 27(7): 2157.

[105] Yu Y, Hu Q, Liu J, et al. Isolation, purification and identification of immunologically active peptides from Hericium erinaceus[J]. Food Chem Toxicol, 2021, 151: 112111.

[106] Lee SR, Jung K, Noh HJ, et al. A new cerebroside from the fruiting bodies of Hericium erinaceus and its applicability to cancer treatment[J]. Bioorg Med Chem Lett, 2015, 25(24): 5712-5715.

[107] Hirokazu K, Motoharu A, Takashi M, et al. A novel fatty acid from the mushroom Hericium erinaceum[J]. Agric Biol Chem, 1990, 54(5): 1329-1331.

[108] Kuwahara S, Morihiro E, Nemoto A, et al. Synthesis and absolute configuration of a cytotoxic fatty acid isolated from the mushroom, Hericium erinaceum [J]. Biosci Biotechnol Biochem, 1992, 56(9): 1417-1419.

[109] Miyazawa M, Matsuda N, Tamura N, et al. Characteristic flavor of volatile oil from dried fruiting bodies of Hericium erinaceus (Bull. : Fr.) Pers[J]. J Essent Oil Res, 2008, 20(5): 420-423.

[110] Corana F, Cesaroni V, Mannucci B, et al. Array of metabolites in Italian Hericium erinaceus mycelium, primordium, and sporophore [J]. Molecules, 2019, 24( 19): 3511.

[111] Freel KC, Nam SJ, Fenical W, et al. Evolution of secondary metabolite genes in three closely related marine actinomycete species[J]. Appl Environ Microbiol, 2011, 77(20): 7261-7270.

[112] Wu J, Kawagishi H. Plant growth regulators from mushrooms[J]. J Antibiot, 2020, 73(10): 657-665.

[113] Hirokazu K, Motoharu A, Hideki S, et al. Hericenones C, D and E, stimulators of nerve growth factor (NGF)-synthesis, from the mushroom Hericium erinaceum[J]. Tetrahedron Lett, 1991, 32(35): 4561-4564.

[114] Wu J, Uchida K, Yoshikawa A, et al. “Fruiting liquid” of mushroom-forming fungi, a novel source of bioactive compounds-fruiting-body inducer and HIF and Axl inhibitors[J]. J Agric Food Chem, 2023, 71(36): 13338-13345.

[115] Singh U, Das K. Hericium rajendrae sp. nov. (Hericiaceae, Russulales): an edible mushroom from Indian Himalaya[J]. Nova Hedwigia, 2019, 108(3): 505-515.

[116] Chen ZG, Bishop KS, Tanambell H, et al. Characterization of the bioactivities of an ethanol extract and some of its constituents from the New Zealand native mushroom Hericium novae-zealandiae[J]. Food Funct, 2019, 10(10): 6633-6643.

[117] Chen J, Zeng X, Yang YL, et al. Genomic and transcriptomic analyses reveal differential regulation of diverse terpenoid and polyketides secondary metabolites in Hericium erinaceus[J]. Sci Rep, 2017, 7(1): 10151.

[118] Gong W, Wang Y, Xie C, et al. Whole genome sequence of an edible and medicinal mushroom, Hericium erinaceus (Basidiomycota, fungi) [J]. Genomics, 2020, 112(3): 2393-2399.

[119] Gong M, Zhang H, Wu D, et al. Key metabolism pathways and regulatory mechanisms of high polysaccharide yielding in Hericium erinaceus[J]. BMC Genomics, 2021, 22(1): 160.

[120] Zhang C, Xu L, Li J, et al. Genome sequencing of Hericium coralloides by a combination of PacBio RS II and next-generation sequencing platforms[J]. Int J Genomics, 2022, 2022: 4017654.

[121] Wei J, Cheng M, Zhu Jf, et al. Comparative genomic analysis and metabolic potential profiling of a novel culinary-medicinal mushroom, Hericium rajendrae (Basidiomycota) [J]. J Fungi, 2023, 9( 10): 1018.

[122] Zhang N, Tang Z, Zhang J, et al. Comparative transcriptome analysis reveals the genetic basis underlying the biosynthesis of polysaccharides in Hericium erinaceus[J]. Bot Stud, 2019, 60(1): 15.

[123] Zeng X, Ling H, Yang J, et al. Proteome analysis provides insight into the regulation of bioactive metabolites in Hericium erinaceus[J]. Gene, 2018, 666: 108-115.

[124] Kenmoku H, Kato N, Shimada M, et al. Isolation of (-)-cyatha-3,12-diene, a common biosynthetic intermediate of cyathane diterpenoids, from an erinacine-producing basidiomycete, Hericium erinaceum, and its formation in a cell-free system [J]. Tetrahedron Lett, 2001, 42( 42): 7439-7442.

[125] Shen T, Morlock G, Zorn H. Hericium erinaceus production of cyathane type secondary metabolites by submerged cultures of and evaluation of their antibacterial activity by direct bioautography[J]. Fun Biol Biotech, 2015, 2: 8.

[126] Yang YL, Zhang S, Ma K, et al. Discovery and characterization of a new family of diterpene cyclases in bacteria and fungi[J]. Angew Chem Int Edit, 2017, 56(17): 4749-4752.

[127] Liu C, Minami A, Ozaki T, et al. Efficient reconstitution of Basidiomycota diterpene erinacine gene cluster in Ascomycota host Aspergillus oryzae based on genomic DNA sequences[J]. J Am Chem Soc, 2019, 141(39): 15519-15523.

[128] Ma K, Zhang Y, Guo C, et al. Reconstitution of biosynthetic pathway for mushroom-derived cyathane diterpenes in yeast and generation of new “non-natural” analogues[J]. Acta Pharm Sin B, 2021, 11(9): 2945-2956.

[129] Saito T, Aoki F, Hirai H, et al. Erinacine E as a kappa opioid receptor agonist and its new analogs from a basidiomycete, Hericium ramosum[J]. J Antibiot, 1998, 51(11): 983-990.

[130] Gilchrist CLM, Chooi YH. Clinker and clustermap.js: automatic generation of gene cluster comparison figures[J]. Bioinformatics, 2021, 37(16): 2473-2475.

[131] Han H, Yu C, Qi J, et al. High-efficient production of mushroom polyketide compounds in a platform host Aspergillus oryzae[J]. Microb Cell Factories, 2023, 22(1): 60.

[132] He X, Wang X, Fang J, et al. Structures, biological activities, and industrial applications of the polysaccharides from Hericium erinaceus (Lion’s mane) mushroom: a review[J]. Int J Biol Macromol, 2017, 97: 228-237.

[133] Obara Y, Nakahata N. The signaling pathway of neurotrophic factor biosynthesis[J]. Drug News Perspect, 2002, 15(5): 290-298.

[134] Allen SJ, Dawbarn D. Clinical relevance of the neurotrophins and their receptors[J]. Clin Sci, 2006, 110(2): 175-191.

[135] Shimbo M, Kawagishi H, Yokogoshi H. Erinacine A increases catecholamine and nerve growth factor content in the central nervous system of rats[J]. Nutr Res, 2005, 25(6): 617-623.

[136] Hu JH, Li IC, Lin TW, et al. Absolute bioavailability, tissue distribution, and excretion of erinacine S in Hericium erinaceus mycelia[J]. Molecules, 2019, 24(8): 1624.

[137] Tsai PC, Wu YK, Hu JH, et al. Preclinical bioavailability, tissue distribution, and protein binding studies of erinacine A, a bioactive compound from Hericium erinaceus mycelia using validated LC-MS/MS method[J]. Molecules, 2021, 26(15): 4510.

[138] Friden PM, Walus LR, Watson P, et al. Blood-brain barrier penetration and in vivo activity of an NGF conjugate[J]. Science, 1993, 259(5093): 373-377.

[139] Tzeng TT, Chen CC, Chen CC, et al. The cyanthin diterpenoid and sesterterpene constituents of Hericium erinaceus mycelium ameliorate Alzheimer’s disease-related pathologies in APP/PS1 transgenic mice[J]. Int J Mol Sci, 2018, 19(2): 598.

[140] Lee KC, Kuo HC, Shen CH, et al. A proteomics approach to identifying novel protein targets involved in erinacine A-mediated inhibition of colorectal cancer cells’ aggressiveness[J]. Int J Mol Cell Med, 2017, 21(3): 588-599.

[141] Chiu CH, Chyau CC, Chen CC, et al. Erinacine A-enriched Hericium erinaceus mycelium produces antidepressant-like effects through modulating BDNF/PI3K/Akt/GSK-3β signaling in mice[J]. Int J Mol Sci, 2018, 19(2): 341.

[142] Lee LY, Chou W, Chen WP, et al. Erinacine A-enriched Hericium erinaceus mycelium delays progression of age-related cognitive decline in senescence accelerated mouse prone 8 (SAMP8) mice[J]. Nutrients, 2021, 13(10): 3659.

[143] Roda E, Priori EC, Ratto D, et al. Neuroprotective metabolites of Hericium erinaceus promote neuro-healthy aging[J]. Int J Mol Sci, 2021, 22(12): 6379.

[144] Valu MV, Soare LC, Ducu C, et al. Hericium erinaceus (Bull.) Pers. ethanolic extract with antioxidant properties on scopolamine-induced memory deficits in a zebrafish model of cognitive impairment[J]. J Fungi, 2021, 7(6): 477.

[145] Lin YC, Wang JY, Wang KC, et al. Differential regulation of amyloid precursor protein sorting with pathological mutations results in a distinct effect on amyloid-β production[J]. J Neurochem, 2014, 131(4): 407-412.

[146] Tsatsanis A, Wong BX, Gunn AP, et al. Amyloidogenic processing of Alzheimer’s disease β-amyloid precursor protein induces cellular iron retention[J]. Mol Psychiatry, 2020, 25(9): 1958-1966.

[147] Huang HT, Ho CH, Sung HY, et al. Hericium erinaceus mycelium and its small bioactive compounds promote oligodendrocyte maturation with an increase in myelin basic protein[J]. Sci Rep, 2021, 11(1): 6551.

[148] Cordaro M, Salinaro AT, Siracusa R, et al. Key mechanisms and potential implications of Hericium erinaceus in NLRP3 inflammasome activation by reactive oxygen species during Alzheimer’s disease[J]. Antioxidants, 2021, 10(11): 1664.

[149] Rascher M, Wittstein K, Winter B, et al. Erinacine C activates transcription from a consensus ETS DNA binding site in astrocytic cells in addition to NGF induction[J]. Biomolecules, 2020, 10(10): 1440.

[150] Phan CW, Lee GS, Hong SL, et al. Hericium erinaceus (Bull. : Fr) Pers. cultivated under tropical conditions: isolation of hericenones and demonstration of NGF-mediated neurite outgrowth in PC12 cells via MEK/ERK and PI3K-Akt signaling pathways[J]. Food Funct, 2014, 5(12): 3160-3169.

[151] Ratto D, Corana F, Mannucci B, et al. Hericium erinaceus improves recognition memory and induces hippocampal and cerebellar neurogenesis in frail mice during aging[J]. Nutrients, 2019, 11(4): 715.

[152] Kim YO, Lee SW, Oh CH, et al. Hericium erinaceus suppresses LPS-induced pro-inflammation gene activation in RAW264.7 macrophages[J]. Int Immunopharmacol, 2012, 34(3): 504-512.

[153] Li QZ, Wu D, Chen X, et al. Chemical compositions and macrophage activation of polysaccharides from Leon’s mane culinary-medicinal mushroom Hericium erinaceus (Higher Basidiomycetes) in different maturation stages[J]. Int J Med Mushrooms, 2015, 17(5): 443-452.

[154] Mori K, Ouchi K, Hirasawa N. The anti-inflammatory effects of Lion’s mane culinary-medicinal mushroom, Hericium erinaceus (Higher Basidiomycetes) in a coculture system of 3T3-L 1 adipocytes and RAW264 macrophages [J]. Int J Med Mushrooms, 2015, 17(7): 609-618.

[155] Kushairi N, Phan CW, Sabaratnam V, et al. Lion’s mane mushroom, Hericium erinaceus (Bull. : Fr.) Pers. suppresses H₂O₂-induced oxidative damage and LPS-induced inflammation in HT22 hippocampal neurons and BV2 microglia[J]. Antioxidants, 2019, 8(8): 261.

[156] Noh HJ, Yoon JY, Kim GS, et al. Benzyl alcohol derivatives from the mushroom Hericium erinaceum attenuate LPS-stimulated inflammatory response through the regulation of NF-κB and AP-1 activity[J]. Int Immunopharmacol, 2014, 36(5): 349-354.

[157] Kim SP, Moon E, Nam SH, et al. Hericium erinaceus mushroom extracts protect infected mice against Salmonella typhimurium-induced liver damage and mortality by stimulation of innate immune cells[J]. J Agric Food Chem, 2012, 60(22): 5590-5596.

[158] Kim SP, Park SO, Lee SJ, et al. A polysaccharide isolated from the liquid culture of Lentinus edodes (Shiitake) mushroom mycelia containing black rice bran protects mice against Salmonellosis through upregulation of the Th 1 immune reaction [J]. J Agric Food Chem, 2014, 62(11): 2384-2391.

[159] Ren L, Perera C, Hemar Y. Antitumor activity of mushroom polysaccharides: a review[J]. Food Funct, 2012, 3(11): 1118-1130.

[160] Lu CC, Huang WS, Lee KF, et al. Inhibitory effect of erinacines A on the growth of DLD-1 colorectal cancer cells is induced by generation of reactive oxygen species and activation of p70S6K and p21[J]. J Funct Food, 2016, 21: 474-484.

[161] Lee KC, Lee KF, Tung SY, et al. Induction apoptosis of erinacine A in human colorectal cancer cells involving the expression of TNFR, Fas, and Fas ligand via the JNK/p300/p50 signaling pathway with histone acetylation[J]. Front Pharmacol, 2019, 10: 1174.

[162] Tung SY, Lee KC, Lee KF, et al. Apoptotic mechanisms of gastric cancer cells induced by isolated erinacine S through epigenetic histone H3 methylation of FasL and TRAIL[J]. Food Funct, 2021, 12(8): 3455-3468.

[163] Kuo HC, Kuo YR, Lee KF, et al. A comparative proteomic analysis of erinacine A’s inhibition of gastric cancer cell viability and invasiveness[J]. Cell Physiol Biochem, 2017, 43(1): 195-208.

[164] Kah HW, Sabaratnam V, Abdullah N, et al. The effects of cultivation techniques and processing on antimicrobial and antioxidant activities of extracts of Hericuem erinaceus (Bull. : Fr.) Pers.[J]. Food Technol Biotechnol, 2009, 47(1): 47-55.

[165] Li IC, Lee LY, Chen YJ, et al. Erinacine A-enriched Hericium erinaceus mycelia promotes longevity in Drosophila melanogaster and aged mice[J]. PLoS One, 2019, 14(5): e0217226.

[166] Thung I, Aramin H, Vavinskaya V, et al. Review article: the global emergence of Helicobacter pylori antibiotic resistance[J]. Aliment Pharmacol Ther, 2016, 43(4): 514-533.

[167] Vértesy LD, Kurz MD, Schindler PD et al.New derivatives of phthalaldehyde, process for their preparation and their use[P]. 1998-09-08.

[168] Mori K, Kikuchi H, Obara Y, et al. Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation[J]. Phytomedicine, 2010, 17(14): 1082-1085.

[169] Abdulla MA, Fard AA, Sabaratnam V, et al. Potential activity of aqueous extract of culinary-medicinal lion’s mane mushroom, Hericium erinaceus (Bull. : Fr.) Pers. (Aphyllophoromycetideae) in accelerating wound healing in rats[J]. Int J Med Mushrooms, 2011, 13(1): 33-39.

[170] Noh HJ, Yang HH, Kim GS, et al. Chemical constituents of Hericium erinaceum associated with the inhibitory activity against cellular senescence in human umbilical vascular endothelial cells[J]. J Enzym Inhib Med Chem, 2015, 30(6): 934-940.

[171] Li IC, Chen YL, Lee LY, et al. Evaluation of the toxicological safety of erinacine A-enriched Hericium erinaceus in a 28-day oral feeding study in Sprague-Dawley rats[J]. Food Chem Toxicol, 2014, 70: 61-67.

[172] Li IC, Chen YL, Chen WP, et al. Genotoxicity profile of erinacine A-enriched Hericium erinaceus mycelium[J]. Toxicol Rep, 2014, 1: 1195-1201.

[173] Širić I, Humar M, Kasap A, et al. Heavy metal bioaccumulation by wild edible saprophytic and ectomycorrhizal mushrooms[J]. Environ Sci Pollut Res, 2016, 23(18): 18239-18252.

[174] Jia FJ, Wang YM, Gong ZQ, et al. Study on quality and safety risk factors of edible fungi and preventive measures: take China as an example[J]. OALib, 2016, 3(11): 1-10.

[175] Makhamrueang N, Sirilun S, Sirithunyalug J, et al. Effect of pretreatment processes on biogenic amines content and some bioactive compounds in Hericium erinaceus extract[J]. Foods, 2021, 10(5): 996.

[176] Zhang Y, Liu L, Bao L, et al. Three new cyathane diterpenes with neurotrophic activity from the liquid cultures of Hericium erinaceus[J]. J Antibiot, 2018, 71(9): 818-821.

[177] Zheng Z, Chen B, Wang K, et al. A concise total synthesis and PPAR activation activity of hericerin from Hericium erinaceum[J]. J Antibiot, 2020, 73(9): 646-649.

Funding

National Natural Science Foundation of China(31800031)

National Natural Science Foundation of China(32370069)

National Natural Science Foundation of China(U22A20369)

Key R&D Projects in Shaanxi Province of China(2023-YBSF-164)

China Postdoctoral Science Foundation(2019M653760)